Certified by Founder Lodge
Vensana Capital
United States - ND
INVESTOR
1 Disclosed Funding Rounds $37,900,000
10 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Vensana Capital is a venture capital & growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical techn
| Company | Date | Round | Raised |
|---|---|---|---|
 Volta Medical |
January, 06 ,2023 | Series B | $37,900,000 |
 Cleerly |
July, 25 ,2022 | Series C | $223,000,000 |
 Relievant Medsystems, Inc. |
April, 21 ,2023 | Unknown | $50,000,000 |
 Artelon |
May, 25 ,2023 | Series B | $20,000,000 |
 SpyGlass Pharma, Inc. |
July, 11 ,2023 | Series C | $90,000,000 |
 Evident Vascular, Inc. |
October, 18 ,2023 | Series A | $35,000,000 |
 Elucent Medical, Inc. |
April, 11 ,2024 | Series C | $42,500,000 |
 iVEAcare, Inc. |
April, 23 ,2024 | Series A | $27,500,000 |
 Alleviant Medical |
January, 16 ,2025 | Unknown | $90,000,000 |
 Luna Diabetes |
August, 26 ,2025 | Series A | $23,600,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
